Travere Therapeutics Inc (TVTX)
EBITDA Growth
-793.80%
Quarterly · Period ending:
TVTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-793.80%period ending
Latest reported-793.80%period ending
TVTX Quarterly EBITDA YoY % (192.59% → -793.80%)
Year-over-year change
High-resolution chart · PNG
TVTX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -793.7969% | |
| 63.922% | |
| 98.6089% | |
| 208.4101% | |
| 107.313% | |
| 79.2602% | |
| 38.4849% | |
| 45.5247% | |
| 35.9265% | |
| -41.4533% | |
| -37.8844% | |
| 0.0053% | |
| -57.5645% | |
| -31.2221% | |
| -32.4178% | |
| -228.3254% | |
| -103.3356% | |
| -57.2903% | |
| 63.4588% | |
| -101.6254% | |
| -77.1556% | |
| -452.9049% | |
| -444.2866% | |
| 58.2134% | |
| 46.4416% | |
| 75.2515% | |
| -917.1153% | |
| 42.0783% | |
| -67.2864% | |
| -129.1899% | |
| 140.5573% | |
| -226.2189% | |
| -77.4772% | |
| -59.315% | |
| 19.8302% | |
| 44.7557% | |
| -102.0915% | |
| -483.9446% | |
| 79.3456% | |
| -182.271% | |
| 79.1357% | |
| -238.8095% | |
| 54.069% | |
| 100% | |
| 68.4255% | |
| 5.5752% | |
| -234.8982% | |
| -967.0698% | |
| -1,096.3534% | |
| -24,081.7852% | |
| -167,622.2665% | |
| -48,687.7861% | |
| 1,700.6296% | |
| 100% | |
| 0.496% | |
| -330.9773% | |
| 2.3617% | |
| 54.3465% | |
| -196.737% | |
| -82.6435% | |
| 53.4768% | |
| 1.0158% | |
| 0% | |
| -56.2926% | |
| -119.4754% | |
| 192.5948% |